®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
April 29, 2016
Bloom Burton's analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN
Bloom Burton’s analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN
Click on the image to view the full video.
RELATED NEWS
See All News
The Globe and Mail | Rare Milestone Approaches for Canadian Biotech Sector as Aurinia Awaits FDA OK to Sell New Drug
Grennbrook TMS Closes US$30 Million Credit facility with Oxford Finance
COVID-19: A Shot in the Arm for Canadian Biotech
The Globe and Mail | Biomedical Sector Continues Growth Streak
AceAge Closes Strategic Financing Led by Longliv Ventures, a Member of the CK Hutchison Holdings Group
The Pharma Podcast with Sam Tarantino
Gordon Keller Receives the 2020 Bloom Burton Award
BNN Bloomberg | Brian Bloom on Moderna’s COVID-19 Vaccine
BNN Bloomberg | Brian Bloom on the Pfizer and BioNTech COVID-19 Vaccine
Newtopia Announces Closing of C$7.5 Million Bought Deal Offering
